Group 1 - The core announcement is about the dividend distribution of the funds managed by QuanGuo and YuanXin YongFeng, with specific details on the amounts and performance of the funds [1][2][3] - QuanGuo JiaYuan three-year holding period mixed fund has a scale of 1.006 billion and a year-to-date net value growth rate of 20.91% as of December 26 [1][3] - The dividend for both A and C class shares of QuanGuo JiaYuan is set at 0.30 yuan per 10 fund shares [2][3] Group 2 - YuanXin YongFeng's medical health fund has a total scale of 1.078 billion and a year-to-date net value growth rate of 31.16% as of December 26 [1][4] - The dividend for A class shares of YuanXin YongFeng Medical Health is 3.3 yuan per 10 fund shares, while C class shares are 1.3 yuan per 10 fund shares [1][4] - Both funds are announcing their first dividend distribution for the year 2025, with specific reference dates for profit distribution [3][4]

Core Viewpoint - The recent trend of "secondary offerings" in the public fund market reflects changes in market conditions, channel strategies, and investor behavior, with several high-performing funds launching secondary offerings through bank channels [1][2]. Group 1: Secondary Offerings - "Secondary offerings" are not a new concept but have gained traction recently, indicating a shift in the market environment and investor preferences [2]. - This approach focuses on marketing funds that have demonstrated strong performance over time, enhancing collaboration between fund companies and distribution channels [2][3]. - Compared to new fund launches, secondary offerings benefit from established performance records and better tracking by distribution channels, leading to higher marketing efficiency [2]. Group 2: Performance and Investor Interest - Since July, equity fund performance has significantly improved, leading to increased investor interest and a push from banks to promote high-performing products through secondary offerings [3]. - For instance, the "West China Central Enterprise Preferred Stock" fund has achieved a net value growth rate of 21% since its inception on December 10, 2024, while the "Round Trust Yongfeng Medical Health" fund has seen over 104% growth in the past year [3]. - The rise of secondary offerings is viewed as a way to re-examine existing product value, reducing resource waste from homogeneous new launches and improving market efficiency [3]. Group 3: Considerations for Fund Companies - The enthusiasm for secondary offerings has prompted discussions on maintaining rationality in fundraising, emphasizing the importance of effective channel communication and appropriate investor management [4]. - Fund companies are encouraged to focus on value creation rather than merely increasing scale, and to promote suitable products based on investors' risk tolerance [4]. - Long-term investment behavior should be encouraged, with strategies like dollar-cost averaging to help investors manage risks during volatile market conditions [4].